Valeant Pharmaceuticals International Cash from Investing TTM:

-2.982B for March 31, 2013
View Full Chart

Valeant Pharmaceuticals International Cash from Investing TTM Chart

    Valeant Pharmaceuticals International Historical Cash from Investing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -2.982B
    Dec. 31, 2012 -2.966B
    Sept. 30, 2012 -2.542B
    June 30, 2012 -2.687B
    March 31, 2012 -2.238B
    Dec. 31, 2011 -2.845B
    Sept. 30, 2011 -1.328B
    June 30, 2011 -569.66M
    March 31, 2011 -552.52M
    Dec. 31, 2010 228.94M
    Sept. 30, 2010 267.67M
    June 30, 2010 -52.21M
    March 31, 2010 -779.61M
    Dec. 31, 2009 -742.77M
    Sept. 30, 2009 -750.84M
    June 30, 2009 -759.14M
    March 31, 2009 -20.59M
    Dec. 31, 2008 -107.83M
    Sept. 30, 2008 -103.80M
    June 30, 2008 -132.20M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Investing (TTM)

    Definition: Cash from Investing

    Learn More

    Get data for

    VRX Cash from Investing TTM Benchmarks

    Companies
    Actavis -5.516B
    Mylan -398.28M
    Warner Chilcott -63.00M

    VRX Cash from Investing TTM Rankings

    Overall 39th percentile
    4821 of 8002
    Sector 11th percentile
    575 of 650 in Healthcare
    Industry 7th percentile
    60 of 65 in Drug Manufacturers - Specialty & Generic

    VRX Cash from Investing TTM Range, Past 5 Years

    Minimum -2.982B Mar 2013
    Maximum 267.67M Sep 2010
    Average -1.083B